Antagonistic cross-regulation between Sox9 and Sox10 controls an anti-tumorigenic program in melanoma.
about
CEACAM1: Expression and Role in Melanocyte TransformationHuman bone marrow harbors cells with neural crest-associated characteristics like human adipose and dermis tissuesMethylation-dependent SOX9 expression mediates invasion in human melanoma cells and is a negative prognostic factor in advanced melanomaSOX5 is involved in balanced MITF regulation in human melanoma cells.Expression of SOX10, ABCB5 and CD271 in melanocytic lesions and correlation with survival data of patients with melanoma.SOX9 indirectly regulates CEACAM1 expression and immune resistance in melanoma cells.Systems analysis identifies miR-29b regulation of invasiveness in melanoma.Copy number variation in archival melanoma biopsies versus benign melanocytic lesions.Metastatic melanoma moves on: translational science in the era of personalized medicine.SOX10-MITF pathway activity in melanoma cells.Identification and functional analysis of SOX10 phosphorylation sites in melanoma.Melanoma: Genetic Abnormalities, Tumor Progression, Clonal Evolution and Tumor Initiating Cells.Super-enhancers define a proliferative PGC-1α-expressing melanoma subgroup sensitive to BET inhibition.Transcription factor Sox10 regulates oligodendroglial Sox9 levels via microRNAs.Ligand-activated BMP signaling inhibits cell differentiation and death to promote melanoma.
P2860
Q28072724-45E468A3-2707-4835-AAEC-B1ED22036768Q33880485-74DB6B8D-C1FC-4474-B343-F77E60B0ECB3Q35229597-1FF7CC32-3AB7-4105-85C3-E15B2E0AECD2Q35939947-9307DB5E-FBFB-4D2C-BCDD-E46F2B5DEFACQ36143330-841FE606-4DD1-4816-A75A-E2F39D3DFFA6Q37327450-FC202EDF-3139-433D-A4B8-F81EB3BE272AQ37419437-63C09BFF-D93E-4338-B75B-4CA57D0A89E6Q38381518-1662EEA6-EF34-479D-BD29-7D631FD5F815Q38891959-DAC04A8A-4847-4071-B5D6-F672E087FB62Q47104368-0C61D1D1-1EB1-4D17-94CE-ACC9F560EE2BQ47190315-BC0AB7A4-ADBF-42EB-8CA3-82266134AD2AQ47227422-CE4751EF-880E-422C-BE3E-F1559C74635DQ47750108-6D817008-5175-43EB-B505-B7C4E5DA53B4Q47904370-E3D9FEA1-94E6-4D45-A165-88EADF53DB91Q50088009-D548EF22-49AF-4B12-9838-D44F3639C3E2
P2860
Antagonistic cross-regulation between Sox9 and Sox10 controls an anti-tumorigenic program in melanoma.
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Antagonistic cross-regulation ...... morigenic program in melanoma.
@ast
Antagonistic cross-regulation ...... morigenic program in melanoma.
@en
type
label
Antagonistic cross-regulation ...... morigenic program in melanoma.
@ast
Antagonistic cross-regulation ...... morigenic program in melanoma.
@en
prefLabel
Antagonistic cross-regulation ...... morigenic program in melanoma.
@ast
Antagonistic cross-regulation ...... morigenic program in melanoma.
@en
P2093
P2860
P50
P1433
P1476
Antagonistic cross-regulation ...... umorigenic program in melanoma
@en
P2093
Claudia Matter
Daniela Mihic-Probst
Glenn Merlino
Holger Moch
Jessica Häusel
Julien Debbache
Olga Shakhova
Paul Meltzer
Pravin J Mishra
Raffaella Santoro
P2860
P304
P356
10.1371/JOURNAL.PGEN.1004877
P577
2015-01-28T00:00:00Z